0001493152-21-011863.txt : 20210517 0001493152-21-011863.hdr.sgml : 20210517 20210517161900 ACCESSION NUMBER: 0001493152-21-011863 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 30 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210517 DATE AS OF CHANGE: 20210517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WORLD HEALTH ENERGY HOLDINGS, INC. CENTRAL INDEX KEY: 0000943535 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 592762023 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-30256 FILM NUMBER: 21930948 BUSINESS ADDRESS: STREET 1: 1825 NW CORPORATE BLVD STREET 2: SUITE 110 CITY: BOCA RATON STATE: FL ZIP: 33431 BUSINESS PHONE: 5618700440 MAIL ADDRESS: STREET 1: 1825 NW CORPORATE BLVD STREET 2: SUITE 110 CITY: BOCA RATON STATE: FL ZIP: 33431 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED PLANT PHARMACEUTICALS INC DATE OF NAME CHANGE: 19990622 10-Q 1 form10-q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

MARK ONE

[X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the Quarterly Period ended March 31, 2021; or

[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from ________ to ________

WORLD HEALTH ENERGY HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware		000-30256
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)


1825 NW Corporate Blvd. Suite 110, Boca Raton, FL		33431
(Address of principal executive offices)		Zip Code

(561) 870-0440

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
N/A		N/A		N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	[ ]	Accelerated filer	[ ]
Non-accelerated filer	[ ]	Smaller reporting company	[X]
		Emerging growth company	[ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

As of May 11, 2021, 89,789,407,996 shares of the registrant’s common stock, par value $0.0007 per share, were outstanding.

WORLD HEALTH ENERGY HOLDINGS, INC.

Form 10-Q

March 31, 2021

	Page

PART I — FINANCIAL INFORMATION

Item 1 – Financial Statements – Unaudited

Condensed Consolidated Balance Sheets – March 31, 2021 and December 31, 2020	3

Condensed Consolidated Statements of Operations for the three months ended March 31, 2021 and 2020	4

Condensed Consolidated Statement of Changes in Stockholders’ Equity for the three months ended March 31, 2021 and 2020	5

Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2021 and 2020	6

Notes to Condensed Consolidated Financial Statements	7

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations	12

Item 3 – Quantitative and Qualitative Disclosures About Market Risk	15

Item 4 – Controls and Procedures	15

PART II — OTHER INFORMATION

Item 1 – Legal Proceedings	16

Item 1A – Risk Factors	16

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds	16

Item 3 – Defaults upon Senior Securities	16

Item 4 – Mine Safety Disclosures	16

Item 5 – Other Information	16

Item 6 – Exhibits	16

Exhibit Index	16

SIGNATURES	17

WORLD HEALTH ENERGY HOLDINGS, INC.

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF MARCH 31, 2021

WORLD HEALTH ENERGY HOLDINGS, INC .

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF MARCH 31, 2021

IN U.S. DOLLARS

TABLE OF CONTENTS

	Page
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:
Condensed Consolidated Balance sheets as of March 31, 2021 (unaudited), and December 31, 2020	3
Condensed Consolidated Statements of Comprehensive Loss for three months ended March 31, 2021 and 2020 (unaudited)	4
Condensed Consolidated Statements of stockholders’ deficit for the period of three months ended March 31, 2021 (unaudited) and the year ended December 31, 2020	5
Condensed Consolidated Statements of cash flows for the three months ended March 31, 2021 and 2020 (unaudited)	6
Notes to unaudited condensed consolidated financial statements	7 - 11

WORLD HEALTH ENERGY HOLDINGS, INC .

CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. dollars except share and per share data)

	March 31,			December 31,
	2021			2020
Assets		(Unaudited)
Current Assets
Cash and cash equivalents		141,868			359,949
Accounts receivable, net		13,360			5,086
Other current assets		47,205			42,178
Total Current assets		202,433			407,213

Right Of Use asset arising from operating lease		230,761			-
Long term prepaid expenses		23,995			24,883

Property and Equipment, Net		26,270			26,054

Total assets		483,459			458,150

Liabilities and Shareholders’ Deficit
Current Liabilities
Accounts payable		20,860			26,284
Right Of Use liabilities arising from operating lease		39,610			-
Other accounts liabilities		531,580			496,874
Total current liabilities		592,050			523,158

Liability for employee rights upon retirement		133,364			104,850
Long term loan from parent company		1,812,704			1,812,704
Right Of Use liabilities arising from operating lease		193,994

Total liabilities		2,732,112			2,440,712

Stockholders’ Deficit
Preferred stock, par $0.0007, 10,000,000 shares authorized, 5,000,000 shares issued and outstanding as of March 31, 2021 and December 31, 2020.		3,500			3,500
Series B Convertible Preferred stock, par $0.0007, 3,870,000 shares authorized, 3,870,000 shares issued and outstanding as of March 31, 2021 and December 31, 2020.		2,709			2,709
Common stock, par $0.0007, 110,000,000,000 shares authorized, 89,789,407,996 shares issued and outstanding at March 31, 2021 and December 31, 2020.		62,852,585			62,852,585
Additional paid-in capital		(63,339,224	)		(63,339,224	)
Foreign currency translation adjustments		(5,495	)		(5,495	)
Accumulated deficit		(1,762,728	)		(1,496,637	)
Total stockholders’ deficit		(2,248,653	)		(1,982,562	)
Total liabilities and stockholders’ deficit		483,459			458,150

The accompanying notes are an integral part of the condensed consolidated financial statements.

WORLD HEALTH ENERGY HOLDINGS, INC .

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(U.S. dollars except share and per share data)

	Three months ended
	March 31
	2021			2020
	(Unaudited)

Revenues		32,649			3,516

Research and development expenses		(172,771	)		(99,948	)
General and administrative expenses		(124,485	)		(57,406	)
Operating loss		(264,607	)		(153,838	)
Financing expenses, net		(1,484	)		(9,208	)
Net loss		(266,091	)		(163,046	)

Comprehensive loss		(266,091	)		(163,046	)

Loss per share (basic and diluted)		(0.00	)		(0.00	)

The accompanying notes are an integral part of the condensed consolidated financial statements.

WORLD HEALTH ENERGY HOLDINGS, INC .

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

(U.S. dollars, except share and per share data)

	Preferred Stock, $0.0007, Par Value				Preferred Stock B, $0.0007, Par Value				Common Stock, $0.0007, Par Value				Additional			Foreign currency						Total Company’s
	Number of Shares		Amount		Number of Shares		Amount		Number of Shares		Amount		paid-in capital			translation adjustments			Accumulated deficit			stockholders’ equity
BALANCE AT JANUARY 1, 2020		-		-		3,870,000		2,709		-		-		(2,681	)		(5,495	)		(623,844	)		(629,311	)
CHANGES DURING THE PERIOD OF THREE MONTHS ENDED MARCH 31, 2020:
Comprehensive loss for three month ended March 31, 2020		-		-		-		-		-		-		-			-			(163.046	)		(163,046	)
BALANCE AT MARCH 31, 2020 (Unaudited)		-		-		3,870,000		2,709		-		-		(2,681	)		(5,495	)		(786,890	)		(792,357	)

	Preferred Stock, $0.0007, Par Value				Preferred Stock B, $0.0007, Par Value				Common Stock, $0.0007, Par Value				Additional			Foreign currency						Total Company’s
	Number of Shares		Amount		Number of Shares		Amount		Number of Shares		Amount		paid-in capital			translation adjustments			Accumulated deficit			stockholders equity
BALANCE AT JANUARY 1, 2021		5,000,000		3,500		3,870,000		2,709		89,789,407,996		62,852,585		(63,339,224	)		(5,495	)		(1,496,637	)		(1,982,562	)
CHANGES DURING THE PERIOD OF THREE MONTHS ENDED MARCH 31, 2021:
Comprehensive loss for three month ended March 31, 2021		-		-		-		-		-		-		-			-			(266,091	)		(266,091	)
BALANCE AT MARCH 31, 2021 (Unaudited)		5,000,000		3,500		3,870,000		2,709		89,789,407,996		62,852,585		(63,339,224	)		(5,495	)		(1,762,728	)		(2,248,653	)

The accompanying notes are an integral part of the condensed consolidated financial statement

WORLD HEALTH ENERGY HOLDINGS, INC .

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. dollars except)

	Three months ended
	March 31,
	2021			2020
	(Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss for the period		(266,091	)		(163,046	)
Adjustments required to reconcile net loss for the period to net cash used in operating activities:
Depreciation and amortization		13,597			10,362
Increase in liability for employee rights upon retirement		28,514			2,777
Decrease in accounts receivable		(8,274	)		(1,738	)
Decrease (increase) in other current assets		(4,139	)		(12,719	)
Increase (decrease) in accounts payable		(5,422	)		7,983
Increase in other accounts liabilities		37,178			31,606
Net cash used in operating activities		(204,637	)		(124,775	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Loans granted to related parties		-			(228,898	)
Proceeds from related parties		3,521			-
Purchase of property and equipment		(1,668	)		(7,675	)
Net cash used in investing activities		1,853			(236,573	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of lease liability		(15,297	)		(6,942	)
Loan received from parent company		-			91,785
Net cash provided by (used in) financing activities		(15,297	)		84,843

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(218,081	)		(276,505	)

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD		359,949			359,461

CASH AND CASH EQUIVALENTS AT END OF PERIOD		141,868			82,956
Supplemental disclosure of cash flow information:
Non cash transactions:
Initial recognition of operating lease right-of-use assets		242,906			-

Initial recognition of operating lease liability		(242,906	)		-

The accompanying notes are an integral part of the condensed consolidated financial statement

WORLD HEALTH ENERGY HOLDINGS, INC .

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

NOTE 1 – GENERAL

Operations

World Health Energy Holdings, Inc., (the “Company” or “WHEN”), was formed on May 21, 1986, under the laws of the State of Delaware. The Company has invested in and abandoned a variety of software programs that it strove to commercialize.

UCG, INC. (the “UCG”) was incorporated on September 13, 2017, under the laws of the State of Florida. The Company wholly-owns the issued and outstanding shares of RNA Ltd. (Hereinafter: “RNA”).

RNA is primarily a research and development company that has been performing software design work for UCG in the field of cybersecurity under the terms of development agreement between UCG and RNA. UCG is primarily engaged in the marketing and distribution of cybersecurity related products.

In anticipation of the transaction contemplated under the Merger Agreement, SG 77 Inc. a Delaware Corporation and a wholly-owned subsidiary of UCG (“SG”), was incorporated on April 16, 2020 and all of the cybersecurity rights and interests held by UCG, including the share ownership of RNA, were assigned to SG.

Merger Transaction

On April 27, 2020, the Company completed a reverse triangular merger pursuant to the Agreement and Plan of Merger (the “Merger Agreement”) among WHEN, R2GA, Inc., a Delaware corporation and a wholly owned subsidiary of WHEN (“Sub”), UCG, SG, and RNA. Under the terms of the Merger Agreement, R2GA merged with SG, with SG remaining as the surviving corporation and a wholly-owned subsidiary of the WHEN (the “Merger”). The Merger was effective as of April 27, 2020 whereby SG became a direct and wholly owned subsidiary of WHEN and RNA indirect wholly owned subsidiary of the Company. Each of Gaya Rozensweig and George Baumeohl, directors of the Company, are also the sole shareholders and directors of the Company.

As consideration for the Merger, WHEN issued to UCG 3,870,000 Series B Convertible Preferred Stock, par value $0.0007 per share, of WHEN (the “Series B Preferred Shares”). Each share of the Series B Preferred Shares will automatically convert into 100,000 shares of WHEN’s common stock, par value $0.0007 (the “Common Stock”), for an aggregate amount of 387,000,000,000 shares of WHEN’s Common Stock, upon the filing with the Secretary of State of Delaware of an amendment to WHEN’s certificate of incorporation increasing the number of authorized shares of Common Stock that the Company is authorized to issue from time to time.

The Company, collectively with SG, Sub and RNA are hereunder referred to as the “Group”.

The transaction was accounted for as a reverse asset acquisition in accordance with generally accepted accounting principles in the United States of America (“GAAP”). Under this method of accounting, SG was deemed to be the accounting acquirer for financial reporting purposes. This determination was primarily based on the facts that, immediately following the Merger: (i) SG’s stockholders owned a substantial majority of the voting rights in the combined company, (ii) SG designated a majority of the members of the initial board of directors of the combined company, and (iii) SG’s senior management holds all key positions in the senior management of the combined company. As a result of the Recapitalization Transaction, the shareholders of SG received the largest ownership interest in the Company, and SG was determined to be the “accounting acquirer” in the Recapitalization Transaction.

WORLD HEALTH ENERGY HOLDINGS, INC .

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

NOTE 1 – GENERAL (continue)

As a result, the historical financial statements of the Company were replaced with the historical financial statements of SG. The number of shares prior to the reverse capitalization have been retroactively adjusted based on the equivalent number of shares received by the accounting acquirer in the Recapitalization Transaction.

Going concern uncertainty

Since inception, the Group has devoted substantially all its efforts to research and development. The Group is still in its development stage and the extent of the Group’s future operating losses and the timing of becoming profitable, if ever, are uncertain. As of March 31, 2021, the Group had $141,868 of cash and cash equivalents, net losses of $266,091, accumulated deficit of $1,762,728, and a negative working capital of $389,617.

The Group will need to secure additional capital in the future in order to meet its anticipated liquidity needs primarily through the sale of additional Common Stock or other equity securities and/or debt financing. Funds from these sources may not be available to the Group on acceptable terms, if at all, and the Group cannot give assurance that it will be successful in securing such additional capital.

These conditions raise substantial doubt about the Company’s ability to continue to operate as a “going concern.” The Company’s ability to continue operating as a going concern is dependent on several factors, among them is the ability to raise sufficient additional funding.

The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Risk factors

The Group face a number of risks, including uncertainties regarding finalization of the development process, demand and market acceptance of the Group’s products, the effects of technological changes, competition and the development of products by competitors. Additionally, other risk factors also exist, such as the ability to manage growth and the effect of planned expansion of operations on the Group’s future results. In addition, the Group expects to continue incurring significant operating costs and losses in connection with the development of its products and increased marketing efforts. As mentioned above, the Group has not yet generated significant revenues from its operations to fund its activities, and therefore the continuance of its activities as a going concern depends on the receipt of additional funding from its current stockholders and investors or from third parties.

WORLD HEALTH ENERGY HOLDINGS, INC .

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

Unaudited Interim Financial Statements

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiary, prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and with the instructions to Form 10-Q. In the opinion of management, the financial statements presented herein have not been audited by an independent registered public accounting firm but include all material adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the financial condition, results of operations and cash flows for the three-months ended March 31, 2021. However, these results are not necessarily indicative of results for any other interim period or for the year ended December 31, 2021. The preparation of financial statements in conformity with GAAP requires the Company to make certain estimates and assumptions for the reporting periods covered by the financial statements. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts could differ from these estimates.

Certain information and footnote disclosures normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission (“SEC”). These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company’s Annual Report on published on the OTCIQ Alternative Reporting System, for the year ended December 31, 2021.

Principles of Consolidation

The consolidated financial statements are prepared in accordance with US GAAP. The consolidated financial statements of the Company include the Company and its wholly-owned and majority-owned subsidiaries. All inter-company balances and transactions have been eliminated.

Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to the going concern assumptions.

WORLD HEALTH ENERGY HOLDINGS, INC .

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (continue)

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (“ASU”) 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”). The guidance in ASU 2020-06 simplifies the accounting for convertible debt and convertible preferred stock by removing the requirements to separately present certain conversion features in equity. In addition, the amendments in the ASU 2020-06 also simplify the guidance in ASC Subtopic 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity, by removing certain criteria that must be satisfied in order to classify a contract as equity, which is expected to decrease the number of freestanding instruments and embedded derivatives accounted for as assets or liabilities. Finally, the amendments revise the guidance on calculating earnings per share, requiring use of the if-converted method for all convertible instruments and rescinding an entity’s ability to rebut the presumption of share settlement for instruments that may be settled in cash or other assets.

The amendments in ASU 2020-06 are effective for the Company for fiscal years beginning after December 15, 2021. Early adoption is permitted. The guidance must be adopted as of the beginning of the fiscal year of adoption. The Company is currently evaluating the impact of this new guidance, but does not expect it to have a material impact on its financial statements.

NOTE 3 – RELATED PARTIES

Transactions and balances with related parties

	Three months ended March 31
	2021		2020
General and administrative expenses:
Salaries and fees to officers		39,413		15,107

Research and development expenses:
Salaries and fees to officers		22,653		8,536

WORLD HEALTH ENERGY HOLDINGS, INC .

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

NOTE 3 – RELATED PARTIES (continue)

Balances with related parties and officers:

	As of March 31,		As of December 31,
	2021		2020

Other accounts liabilities		183,135		191,994
Long term loan from related party		1,812,704		1,812,704
Liability for employee rights upon retirement		102,516		95,451

NOTE 4 – COMMITMENTS AND CONTINGENCIES

On October 27, 2020 WHEN filed suit in State Court, Palm Beach County, Florida, against FSC Solutions, Inc. (“FSC”), Eli Gal Levy (“EL”) and Padem Consultants Sprl (collectively, the “Defendants”). The suit relates to the Stock Purchase Agreement entered into by WHEN with FSC and its shareholders, which included EL, pursuant to which WHEN acquired all of the issued and outstanding stock of FSC in exchange for the issuance of 70 billion shares of WHEN unregistered common stock. FSC was the putative owner of a software and trading platform which WHEN intended to use to enter into the on-line trading business. Subsequent to the completion of the acquisition, we determined that FSC did not have control over the trading platform and software we expected to acquire and operate. The Suit sought declaratory judgment to unwind the FSC transaction and cancel the shares of WHEN common stock issued in the FSC transaction that are still outstanding.

A hearing was set for January 6, 2021 whereupon mediation was ordered. The Company has been in discussions with EL to resolve this issue.

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

The following discussion should be read in conjunction with the financial statements and related notes contained elsewhere in this Quarterly Report on Form 10-Q, as well as our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 as filed with the Securities and Exchange Commission (the “SEC”) on April 15, 2021. Certain statements made in this discussion are “forward-looking statements” within the meaning of the private securities litigation reform act of 1995,. These statements are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by the Company’s management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used herein, the words “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “future,” “intend,” “plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue” or the negative of these terms and similar expressions as they relate to the Company or the Company’s management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors, including the risks relating to the Company’s business, industry, and the Company’s operations and results of operations and the effects that the COVID-19 outbreak, or similar pandemics, could have on our business. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

The full extent to which the COVID-19 pandemic may directly or indirectly impact our business, results of operations and financial condition will depend on future developments that are uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international customers and markets. We have made estimates of the impact of COVID-19 within our financial statements, and although there is currently no major impact, there may be changes to those estimates in future periods. Actual results may differ from these estimates.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates and actual results. The following discussion should be read in conjunction with our financial statements and notes thereto appearing elsewhere in this report.

Overview

World Health Energy Holdings Inc. (“WHEN”), through its wholly owned subsidiaries SG 77, Inc. (“SG”) and RNA Ltd (“RNA”), is primarily engaged in data security and analytics and provides intelligent security software and services to enterprises and individuals worldwide WHEN leverages artificial intelligence (“AI”) and machine learning to deliver innovative solutions in the areas of cybersecurity, safety focusing on the areas of endpoint security, endpoint management and encryption.

As the digital transformation of enterprises continues to advance, workforces are becoming more dispersed and mobile, and data and applications are increasingly migrating to the cloud. As part of this trend, the number of connected endpoints is growing rapidly, as is their complexity and the volume of data that they process and store. These endpoints, which include smartphones, laptops, desktops, servers, vehicles, industrial equipment and other connected devices in the Internet of Things (“IoT”), are increasingly a target for cyber adversaries. The COVID-19 pandemic has accelerated the decentralization of the workplace prompting many enterprises to shift to substantially remote and mobile work models. At the same time, the threat environment has become increasingly hostile as the number of adversaries grows and the scale and sophistication of their attacks, increasingly focused on the endpoint, continue to develop.

The landscape of increasing vulnerability has created opportunities for secure communications platforms, endpoint cybersecurity and management solutions, analytic tools and related services that help enterprises and individuals to secure their connected endpoints. Our software specializes in data protection, threat detection and response. Our product offerings enable enterprises to protect data stored on premises and in the cloud, confidential data belonging to customers, financial records, strategic and product plans and other intellectual property and, on a parental or guardian level, to monitor minor children’s cyber activities.

We believe that the COVID-19 pandemic, which continues to impact all of society has increased our long-term opportunity to help our customers protect their data and detect threats. Companies around the world now have employees working remotely from potentially vulnerable home networks, accessing critical on-premises data storages and infrastructure through VPNs and sharing information in cloud data stores. We believe this trend is likely to continue in the long-term and that we are striving to capitalize on the opportunity ahead.

Product Offerings & Revenue Model

Our product offerings are comprised of two principal segments, one targeting for commercial enterprises (B2B) and one for the individual users (B2C).

B2B Offerings—The B2B Cybersecurity system software development and implementation program focused on innovative solutions for the constantly evolving cyber challenges of businesses, non-governmental organizations (NGO’s) and governmental entities.

We recently launched OTOGRAPH, our comprehensive cybersecurity and information security system, to enable business enterprises to monitor, analyze and prevent suspicious or harmful behavior on corporate networks and connected devices. The OTOGRAPH is designed to analyze and prevent internal or external abuse or abnormal activity on enterprise devices, such as PCs, mobile phones, servers or any other OS-based IOT device.

The rapid transition to open and cloud-based remote workforce has exposed businesses and organizations across the world to higher risks of cyber-attacks and information security breaches. To enable businesses to better protect their data and workflow, we developed a Business Behavioral Analysis (BBA) system that enables business leaders to track all activity from any given location on a one-stop dashboard. Developed over the past two years, OTOGRAPH provides aggregated data and a wide variety of real-time analytics such as real time monitoring of online behavior, applications and system behavior, data breaches, internal and external connections analytics, productivity analysis and psycholinguistic analysis. Corporations and organizations can then use the dashboard to detect suspicious human or device activities that put their company at risk.

OTOGRAPH was developed based on a state of the art intelligence technology combined with AI technology that processes and analyzes massive amounts of behavioral and communication data and enables organizations to make real time accurate preventive assessments and decisions to protect company assets and ensure operational efficiency. OTOGRAPH deploys a unique Business Behavioral Analysis (BBA) machine learning software. Behavioral digital data is extracted from all endpoint devices that are connected to the company’s network infrastructure – whether physically, wirelessly or remotely. The data is processed and analyzed to learn and to reveal the unique digital behavioral pattern of the organization as a whole and of every endpoint or individual.

OTOGRAPH sets baselines of normal patterns for each, and constantly searches for anomalies – deviations from those expected patterns. The anomalies are detected automatically and instantly, categorized by their type and generate push alerts which are sent to the business leader’s dashboard and enabling him to respond to the threat.

B2C Cybersecurity —The B2C Cybersecurity division targets families concerned with external cyber threats and exposures in addition to monitoring a child’s behavioral patterns that may alert parents to potential tragedies caused by cyber bullying, pedophiles, other predators, and depression.

Our go-to-market strategy focuses principally on generating revenue from software, services and licensing. We intend to sell substantially all of our products and services to distributors and resellers, which will sell to end-user customers, which we refer to in this report as our customers.

Other Corporate Holdings

We currently also have the following subsidiaries.

FSC Solutions, Inc. On June 26, 2015, we entered into a Stock Purchase Agreement (the “Agreement”) with FSC and its shareholders which included Uri Tadelis, our former Chief Executive Officer and Director and our former Directors Chaim J. Lieberman and Gal Levy. The Agreement was effective as of July 1, 2015 which served as the closing date for the acquisition. Pursuant to the terms of the Agreement, we acquired all of the capital stock of FSC in exchange for the issuance of 70 billion shares of our unregistered common stock with the possibility of the issuance of an additional 130 Billion common shares upon FSC meeting certain milestones as outlined in the Agreement. Upon completion of the acquisition of FSC, we intended to employ FSC’s software and trading platform to enter the on-line trading industry. Subsequent to the completion of the acquisition, we determined that FSC did not have control over the trading platform and software we expected to acquire and operate. Please refer to Item 1, Part II, of this report.

World Health Energy, Inc. World Health Energy, Inc. owns an algae-tech business whose primary focus was the production of algae using their proprietary GB3000 growth system. The system quickly and efficiently grows algae for the production of biofuels and food protein. We also sought to produce and market high-quality, low-cost B100 biodiesel. Though, we believe that the Company has been successful in demonstrating the effectiveness of the GB3000 system on a small-scale the Company has not yet been able to raise the necessary capital to implement their technologies on a commercial scale.

Corporate Structure (Diagram)

The corporate structure of the WHEN Group is reflected below in this diagram

Comparison of the Three Months Ended March 31, 2021 to the Three Months Ended March 31, 2020

The following table presents our results of operations for the three months ended March 31, 2021 and 2020

	Three Months Ended
	March 31
	2021			2020

Revenues		32,649			3,516
Operating Expenses
Research and development expenses		(172,771	)		(99,948	)
General and administrative expenses		(124,485	)		(57,406	)
Operating loss		(264,607	)		(153,838	)
Financing expenses, net		(1,484	)		(9,208	)
Net loss		(266,091	)		(163,046	)

Revenues. Revenues for the three months ended March 31, 2021 and 2020 were $32,649 and $3,516, respectively. Revenues were comprised primarily of software license fees.

Research and Development. Research and development expenses consist of salaries and related expenses, consulting fees, service providers’ costs, related materials and overhead expenses. Research and development expenses increased from $99,948 for the three months ended March 31, 2020 to $172,771 for the three months ended March 31, 2021. The increase resulted primarily from increase in salaries and related expenses associated with our development activities.

General and Administrative Expenses. General and administrative expenses consist primarily of salaries and related expenses and other non-personnel related expenses such as legal expenses. General and administrative expenses increased from $57,406 for the three months ended March 31, 2020 to $124,485 for the three months ended March 31, 2021. The increase is primarily attributable to the increase in salaries and related expenses, professional services other non-personnel related expenses.

Financing Expenses, Net. Financing expenses, net decreased from $9,208 for the three months ended March 31, 2020 to $1,484 for the three months ended March 31, 2020. The decrease is mainly a result of currency exchange differences between the Dollar and the New Israeli Shekel.

Net Loss. Net loss for the March 31, 2021 was $266,091 and is primarily attributable to research and development and general and administrative expenses.

Financial Condition, Liquidity and Capital Resources

Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. At March 31, 2021, we had current assets of $202,433 compared to total current assets of $407,213 as of December 31, 2020. At March 31, 2021, we had total assets of $483,459 compared to total assets of $458,150 as of December 31, 2020. The increase in total assets is due to a decrease in related parties balance offset by increase in right of use asset arising from operating lease. At March 31, 2021,we had current liabilities of $592,050 as compared to $523,158 as of December 31, 2020. At March 31, 2021, we had total liabilities of $2,732,112 as compared to $2,440,712 as of December 31, 2020. The increase is mainly attributed to the increase in the balance of employees and related institutions, accrued expenses and right of use liabilities arising from operating lease.

At March 31, 2021, we had a cash balance of $141,868 compared to the cash balance of $359,949 as of December 31, 2020. We have no cash equivalents.

At March 31, 2021, we had a working capital deficiency of $389,617 as compared with a working capital deficiency of $115,945 at December 31, 2020.

We expect that our existing cash and cash equivalents as well as expected revenues will enable us to fund our operations and capital expenditure requirements through the fiscal year-end 2021. Our requirements for additional capital during this period will depend on many factors.

We may seek to raise any necessary additional capital through a combination of private or public equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements. To the extent that we raise additional capital through marketing and distribution arrangements or other collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights, future revenue streams, or product candidates or to grant licenses on terms that may not be favorable to us. If we raise additional capital through private or public equity offerings, the ownership interest of our existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect our stockholders’ rights. If we raise additional capital through debt financing, we may be subject to covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends.

Going Concern

The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern. We have a stockholders’ deficit of $2,248,653 and a working capital deficiency of $389,617 at March 31, 2021 as well as negative operating cash flows. These conditions raise substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

Off-Balance Sheet Arrangements We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures.

We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed by us in reports that we file under the Exchange Act is recorded, processed, summarized and reported as specified in the SEC’s rules and forms and that such information required to be disclosed by us in reports that we file under the Exchange Act is accumulated and communicated to our management, including our Interim Chief Executive Officer, to allow timely decisions regarding required disclosure. Management, with the participation of our Interim Chief Executive Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures as of March 31, 2021. Based on that evaluation, our management, including our Interim Chief Executive Officer, concluded that our disclosure controls and procedures were not effective as of March 31, 2021.

Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. As disclosed in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2020, our management concluded that our internal control over financial reporting was not effective at December 31, 2020. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. The limitation of the Company’s internal control over financial reporting was due to the applied risk-based approach which is indicative of many small companies with limited number of staff in corporate functions. The identified weakness were:

●	Material Weakness – We did not maintain effective controls over certain aspects of the financial reporting process because we (i) lacked a sufficient complement of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate with our financial reporting requirements and (ii) we lacked controls over the disclosure of our business operations.

●	lack of segregation of duties Significant Deficiencies – Inadequate segregation of duties.

Our management believes the weaknesses identified above have not had any material effect on our financial results.

We expect to be materially dependent upon third parties to provide us with accounting consulting services for the foreseeable future which we believe will mitigate the impact of the material weaknesses discussed above. Until such time as we have a chief financial officer with the requisite expertise in U.S. GAAP and establish an audit committee and implement internal controls and procedures, there are no assurances that the material weaknesses and significant deficiencies in our disclosure controls and procedures will not result in errors in our financial statements which could lead to a restatement of those financial statements.

Changes in Internal Controls over Financial Reporting.

Except for the material weakness and associated remediation plan, , there have been no changes in our internal control over financial reporting during the fiscal quarter ended March 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

A hearing was set for January 6, 2021 whereupon mediation was ordered. The Company has been in discussion with EL to resolve this issue.

From time to time we may become involved in various legal proceedings that arise in the ordinary course of business, including actions related to our intellectual property. Although the outcomes of these legal proceedings cannot be predicted with certainty, we are currently not aware of any such legal proceedings that arise in the ordinary course of business, including actions related to our intellectual property. Although the outcomes of these legal proceedings cannot be predicted with certainty, we are currently not aware of any such legal proceedings or claims that we believe, either individually or in the aggregate, will have a material adverse effect on our business, financial condition, or results of operations.

ITEM 1A.

RISK FACTORS

An investment in the Company’s Common Stock involves a number of very significant risks. You should carefully consider the risk factors included in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the SEC on April 15, 2021, in addition to other information contained in our reports and in this quarterly report in evaluating the Company and its business before purchasing shares of our Common Stock. There have been no material changes to our risk factors contained in our Annual Report on Form 10-K for the year ended December 31, 2020.

ITEM 2.

UNREGISTERED SALES OF SECURITIES AND USE OF PROCEEDS

None.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.

MINE SAFETY DISCLOSURES

None.

ITEM 5.

OTHER INFORMATION:

None.

ITEM 6.

EXHIBITS

Exhibit Index:

31.1*		Certification of Interim Chief Executive Officer (Principal Executive Officer and Principal Financial and Accounting Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

32.1*		Certification of Interim Chief Executive Officer (Principal Executive Officer and Principal Financial and Accounting Officer), as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema

101.CAL		XBRL Taxonomy Extension Calculation Linkbase

101.DEF		XBRL Taxonomy Extension Definition Linkbase

101.LAB		XBRL Taxonomy Extension Label Linkbase

101.PRE		XBRL Taxonomy Extension Presentation Linkbase

* Filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

WORLD HEALTH ENERGY HOLDINGS, INC.
(Registrant)

By:	/s/ Giora Rozensweig
	Giora Rozensweig
	Interim Chief Executive Officer
	(Principal Executive Officer and Principal Financial and Accounting Officer)

Date:	May 17, 2021

EX-31.1 2 ex31-1.htm

EXHIBIT 31.1

RULE 13a-14(a) CERTIFICATION

I, Giora Rozensweig, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021, of World Health Energy Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 17, 2021

/s/ Giora Rozensweig

Giora Rozensweig, Interim Chief Executive Officer

(Principal Executive Officer and Principal Financial and Accounting Officer)

EX-32.1 3 ex32-1.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 (AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Quarterly Report on Form 10-Q of World Health Energy Holdings, Inc. (the “Company”) for the for the fiscal quarter ended March 31, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Giora Rozensweig, Interim Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Giora Rozensweig

Giora Rozensweig

Interim Chief Executive Officer (Principal Executive Officer and Principal Financial and Accounting Officer)

May 17, 2021

GRAPHIC 4 image_001.jpg begin 644 image_001.jpg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end EX-101.INS 5 when-20210331.xml XBRL INSTANCE FILE 0000943535 2020-12-31 0000943535 2019-12-31 0000943535 us-gaap:PreferredStockMember 2019-12-31 0000943535 us-gaap:CommonStockMember 2019-12-31 0000943535 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000943535 us-gaap:RetainedEarningsMember 2019-12-31 0000943535 us-gaap:PreferredStockMember 2020-12-31 0000943535 us-gaap:CommonStockMember 2020-12-31 0000943535 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000943535 us-gaap:RetainedEarningsMember 2020-12-31 0000943535 WHEN:MergerAgreementMember WHEN:SeriesBConvertiblePreferredStockMember WHEN:UCGINCMember 2020-04-26 2020-04-27 0000943535 WHEN:MergerAgreementMember WHEN:SeriesBConvertiblePreferredStockMember WHEN:UCGINCMember 2020-04-27 0000943535 WHEN:MergerAgreementMember us-gaap:SeriesBPreferredStockMember 2020-04-26 2020-04-27 0000943535 WHEN:SeriesBConvertiblePreferredStockMember 2020-12-31 0000943535 WHEN:PreferredStockBMember 2019-12-31 0000943535 WHEN:PreferredStockBMember 2020-12-31 0000943535 WHEN:ForeignCurrencyTranslationAdjustmentsMember 2019-12-31 0000943535 WHEN:ForeignCurrencyTranslationAdjustmentsMember 2020-12-31 0000943535 2020-10-26 2020-10-27 0000943535 2021-03-31 0000943535 WHEN:SeriesBConvertiblePreferredStockMember 2021-03-31 0000943535 2020-01-01 2020-03-31 0000943535 2021-01-01 2021-03-31 0000943535 us-gaap:PreferredStockMember 2020-01-01 2020-03-31 0000943535 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0000943535 us-gaap:PreferredStockMember 2020-03-31 0000943535 us-gaap:PreferredStockMember 2021-03-31 0000943535 WHEN:PreferredStockBMember 2020-01-01 2020-03-31 0000943535 WHEN:PreferredStockBMember 2021-01-01 2021-03-31 0000943535 WHEN:PreferredStockBMember 2020-03-31 0000943535 WHEN:PreferredStockBMember 2021-03-31 0000943535 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000943535 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000943535 us-gaap:CommonStockMember 2020-03-31 0000943535 us-gaap:CommonStockMember 2021-03-31 0000943535 WHEN:ForeignCurrencyTranslationAdjustmentsMember 2020-01-01 2020-03-31 0000943535 WHEN:ForeignCurrencyTranslationAdjustmentsMember 2021-01-01 2021-03-31 0000943535 WHEN:ForeignCurrencyTranslationAdjustmentsMember 2020-03-31 0000943535 WHEN:ForeignCurrencyTranslationAdjustmentsMember 2021-03-31 0000943535 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000943535 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000943535 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000943535 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000943535 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000943535 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000943535 us-gaap:RetainedEarningsMember 2020-03-31 0000943535 us-gaap:RetainedEarningsMember 2021-03-31 0000943535 2020-03-31 0000943535 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-03-31 0000943535 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-03-31 0000943535 WHEN:ResearchAndDevelopmentExpensesMember 2021-01-01 2021-03-31 0000943535 WHEN:ResearchAndDevelopmentExpensesMember 2020-01-01 2020-03-31 0000943535 2021-05-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares 10-Q false 2021-03-31 --12-31 WORLD HEALTH ENERGY HOLDINGS, INC. 0000943535 Yes Non-accelerated Filer true false false Yes

-1982562

-629311

-2681

-623844

3500

62852585

-63339224

-1496637

2709

-5495

-2248653

3500

2709

62852585

-5495

-2681

-63339224

-786890

-1762728

-792357

0.0007

10000000

3870000

10000000

3870000

5000000

3870000

5000000

3870000

5000000

3870000

5000000

3870000

110000000000

0.0007

89789407996

-163046

-266091

-163046

-266091

407213

202433

458150

483459

523158

592050

3500

2709

3500

2709

359949

359461

141868

82956

458150

483459

-1496637

-1762728

-63339224

62852585

5086

13360

42178

47205

230761

26054

26270

26284

20860

496874

531580

104850

133364

1812704

2440712

2732112

-5495

39413

15107

22653

8536

1812704

228898

2021

3516

32649

99948

172771

57406

124485

-153838

-264607

-9208

-1484

-163046

-266091

0.00

-0.00

5000000

89789407996

3870000

5000000

3870000

89789407996

359949

141868

-276505

-218081

84843

-15297

91785

6942

15297

-236573

1853

7675

1668

-124775

-204637

31606

37178

7983

-5422

12719

4139

1738

8274

2777

28514

10362

13597

89789407996

3870000

100000

387000000000

183134 191994 102516 95451 3521 -389617

24883

23995

39610

193994

242906 -242906

NOTE 1 – GENERAL   <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 34px"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px">A.</td> <td style="font: 12pt Times New Roman, Times, Serif">Operations</td></tr> </table>   World Health Energy Holdings, Inc., (the “Company” or “WHEN”), was formed on May 21, 1986, under the laws of the State of Delaware. The Company has invested in and abandoned a variety of software programs that it strove to commercialize.   UCG, INC. (the “UCG”) was incorporated on September 13, 2017, under the laws of the State of Florida. The Company wholly-owns the issued and outstanding shares of RNA Ltd. (Hereinafter: “RNA”).   RNA is primarily a research and development company that has been performing software design work for UCG in the field of cybersecurity under the terms of development agreement between UCG and RNA. UCG is primarily engaged in the marketing and distribution of cybersecurity related products.   In anticipation of the transaction contemplated under the Merger Agreement, SG 77 Inc. a Delaware Corporation and a wholly-owned subsidiary of UCG (“SG”), was incorporated on April 16, 2020 and all of the cybersecurity rights and interests held by UCG, including the share ownership of RNA, were assigned to SG.   <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 34px"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px">B.</td> <td style="font: 12pt Times New Roman, Times, Serif">Merger Transaction</td></tr> </table>   On April 27, 2020, the Company completed a reverse triangular merger pursuant to the Agreement and Plan of Merger (the “Merger Agreement”) among WHEN, R2GA, Inc., a Delaware corporation and a wholly owned subsidiary of WHEN (“Sub”), UCG, SG, and RNA. Under the terms of the Merger Agreement, R2GA merged with SG, with SG remaining as the surviving corporation and a wholly-owned subsidiary of the WHEN (the “Merger”). The Merger was effective as of April 27, 2020 whereby SG became a direct and wholly owned subsidiary of WHEN and RNA indirect wholly owned subsidiary of the Company. Each of Gaya Rozensweig and George Baumeohl, directors of the Company, are also the sole shareholders and directors of the Company.   As consideration for the Merger, WHEN issued to UCG 3,870,000 Series B Convertible Preferred Stock, par value $0.0007 per share, of WHEN (the “Series B Preferred Shares”). Each share of the Series B Preferred Shares will automatically convert into 100,000 shares of WHEN’s common stock, par value $0.0007 (the “Common Stock”), for an aggregate amount of 387,000,000,000 shares of WHEN’s Common Stock, upon the filing with the Secretary of State of Delaware of an amendment to WHEN’s certificate of incorporation increasing the number of authorized shares of Common Stock that the Company is authorized to issue from time to time.   The Company, collectively with SG, Sub and RNA are hereunder referred to as the “Group”.   The transaction was accounted for as a reverse asset acquisition in accordance with generally accepted accounting principles in the United States of America (“GAAP”). Under this method of accounting, SG was deemed to be the accounting acquirer for financial reporting purposes. This determination was primarily based on the facts that, immediately following the Merger: (i) SG’s stockholders owned a substantial majority of the voting rights in the combined company, (ii) SG designated a majority of the members of the initial board of directors of the combined company, and (iii) SG’s senior management holds all key positions in the senior management of the combined company. As a result of the Recapitalization Transaction, the shareholders of SG received the largest ownership interest in the Company, and SG was determined to be the “accounting acquirer” in the Recapitalization Transaction.   As a result, the historical financial statements of the Company were replaced with the historical financial statements of SG. The number of shares prior to the reverse capitalization have been retroactively adjusted based on the equivalent number of shares received by the accounting acquirer in the Recapitalization Transaction.   <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 34px"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px">C.</td> <td style="font: 12pt Times New Roman, Times, Serif">Going concern uncertainty</td></tr> </table>   Since inception, the Group has devoted substantially all its efforts to research and development. The Group is still in its development stage and the extent of the Group’s future operating losses and the timing of becoming profitable, if ever, are uncertain. As of March 31, 2021, the Group had $141,868 of cash and cash equivalents, net losses of $266,091, accumulated deficit of $1,762,728, and a negative working capital of $389,617.   The Group will need to secure additional capital in the future in order to meet its anticipated liquidity needs primarily through the sale of additional Common Stock or other equity securities and/or debt financing. Funds from these sources may not be available to the Group on acceptable terms, if at all, and the Group cannot give assurance that it will be successful in securing such additional capital.   These conditions raise substantial doubt about the Company’s ability to continue to operate as a “going concern.” The Company’s ability to continue operating as a going concern is dependent on several factors, among them is the ability to raise sufficient additional funding.   The financial statements do not include any adjustments that might result from the outcome of this uncertainty.   <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 34px"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px">D.</td> <td style="font: 12pt Times New Roman, Times, Serif">Risk factors</td></tr> </table>   The Group face a number of risks, including uncertainties regarding finalization of the development process, demand and market acceptance of the Group’s products, the effects of technological changes, competition and the development of products by competitors. Additionally, other risk factors also exist, such as the ability to manage growth and the effect of planned expansion of operations on the Group’s future results. In addition, the Group expects to continue incurring significant operating costs and losses in connection with the development of its products and increased marketing efforts. As mentioned above, the Group has not yet generated significant revenues from its operations to fund its activities, and therefore the continuance of its activities as a going concern depends on the receipt of additional funding from its current stockholders and investors or from third parties.

NOTE 3 – RELATED PARTIES   <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 34px"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px">A.</td> <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify">Transactions and balances with related parties</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid"> Three months ended March 31</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2021</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2020</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>General and administrative expenses:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 58%; padding-bottom: 1.5pt; padding-left: 10pt">Salaries and fees to officers</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 18%; text-align: right">39,413</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 18%; text-align: right">15,107</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Research and development expenses:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Salaries and fees to officers</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">22,653</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">8,536</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table>     <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 34px"> </td> <td style="width: 24px; padding-left: 10pt; text-indent: -10pt">B.</td> <td style="padding-left: 10pt; text-indent: -10pt">Balances with related parties and officers:</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">As of March 31,</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">As of December 31,</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2021</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2020</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; padding-bottom: 1.5pt">Other accounts liabilities</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 18%; text-align: right">183,135</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 18%; text-align: right">191,994</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Long term loan from related party</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,812,704</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,812,704</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Liability for employee rights upon retirement</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">102,516</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">95,451</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table>

Use of Estimates   The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to the going concern assumptions.

Principles of Consolidation   The consolidated financial statements are prepared in accordance with US GAAP. The consolidated financial statements of the Company include the Company and its wholly-owned and majority-owned subsidiaries. All inter-company balances and transactions have been eliminated.

Unaudited Interim Financial Statements   The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiary, prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and with the instructions to Form 10-Q. In the opinion of management, the financial statements presented herein have not been audited by an independent registered public accounting firm but include all material adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the financial condition, results of operations and cash flows for the three-months ended March 31, 2021. However, these results are not necessarily indicative of results for any other interim period or for the year ended December 31, 2021. The preparation of financial statements in conformity with GAAP requires the Company to make certain estimates and assumptions for the reporting periods covered by the financial statements. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts could differ from these estimates.   Certain information and footnote disclosures normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission (“SEC”). These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company’s Annual Report on published on the OTCIQ Alternative Reporting System, for the year ended December 31, 2021.

<table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="width: 34px"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px">A.</td> <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify">Transactions and balances with related parties</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid"> Three months ended March 31</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2021</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2020</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>General and administrative expenses:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 58%; padding-bottom: 1.5pt; padding-left: 10pt">Salaries and fees to officers</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 18%; text-align: right">39,413</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 18%; text-align: right">15,107</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Research and development expenses:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Salaries and fees to officers</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">22,653</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">8,536</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table>     <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 34px"> </td> <td style="width: 24px; padding-left: 10pt; text-indent: -10pt">B.</td> <td style="padding-left: 10pt; text-indent: -10pt">Balances with related parties and officers:</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">As of March 31,</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">As of December 31,</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2021</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">2020</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; padding-bottom: 1.5pt">Other accounts liabilities</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 18%; text-align: right">183,135</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 18%; text-align: right">191,994</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Long term loan from related party</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,812,704</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,812,704</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Liability for employee rights upon retirement</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">102,516</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">95,451</td> <td style="padding-bottom: 1.5pt"> </td></tr> </table>

The suit relates to the Stock Purchase Agreement entered into by WHEN with FSC and its shareholders, which included EL, pursuant to which WHEN acquired all of the issued and outstanding stock of FSC in exchange for the issuance of 70 billion shares of WHEN unregistered common stock. FSC was the putative owner of a software and trading platform which WHEN intended to use to enter into the on-line trading business.

NOTE 4 – COMMITMENTS AND CONTINGENCIES   On October 27, 2020 WHEN filed suit in State Court, Palm Beach County, Florida, against FSC Solutions, Inc. (“FSC”), Eli Gal Levy (“EL”) and Padem Consultants Sprl (collectively, the “Defendants”). The suit relates to the Stock Purchase Agreement entered into by WHEN with FSC and its shareholders, which included EL, pursuant to which WHEN acquired all of the issued and outstanding stock of FSC in exchange for the issuance of 70 billion shares of WHEN unregistered common stock. FSC was the putative owner of a software and trading platform which WHEN intended to use to enter into the on-line trading business. Subsequent to the completion of the acquisition, we determined that FSC did not have control over the trading platform and software we expected to acquire and operate. The Suit sought declaratory judgment to unwind the FSC transaction and cancel the shares of WHEN common stock issued in the FSC transaction that are still outstanding.   A hearing was set for January 6, 2021 whereupon mediation was ordered. The Company has been in discussions with EL to resolve this issue.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION   Unaudited Interim Financial Statements   The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiary, prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and with the instructions to Form 10-Q. In the opinion of management, the financial statements presented herein have not been audited by an independent registered public accounting firm but include all material adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the financial condition, results of operations and cash flows for the three-months ended March 31, 2021. However, these results are not necessarily indicative of results for any other interim period or for the year ended December 31, 2021. The preparation of financial statements in conformity with GAAP requires the Company to make certain estimates and assumptions for the reporting periods covered by the financial statements. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts could differ from these estimates.   Certain information and footnote disclosures normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission (“SEC”). These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company’s Annual Report on published on the OTCIQ Alternative Reporting System, for the year ended December 31, 2021.   Principles of Consolidation   The consolidated financial statements are prepared in accordance with US GAAP. The consolidated financial statements of the Company include the Company and its wholly-owned and majority-owned subsidiaries. All inter-company balances and transactions have been eliminated.   Use of Estimates   The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to the going concern assumptions.    Recent Accounting Pronouncements   In August 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (“ASU”) 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”). The guidance in ASU 2020-06 simplifies the accounting for convertible debt and convertible preferred stock by removing the requirements to separately present certain conversion features in equity. In addition, the amendments in the ASU 2020-06 also simplify the guidance in ASC Subtopic 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity, by removing certain criteria that must be satisfied in order to classify a contract as equity, which is expected to decrease the number of freestanding instruments and embedded derivatives accounted for as assets or liabilities. Finally, the amendments revise the guidance on calculating earnings per share, requiring use of the if-converted method for all convertible instruments and rescinding an entity’s ability to rebut the presumption of share settlement for instruments that may be settled in cash or other assets.   The amendments in ASU 2020-06 are effective for the Company for fiscal years beginning after December 15, 2021. Early adoption is permitted. The guidance must be adopted as of the beginning of the fiscal year of adoption. The Company is currently evaluating the impact of this new guidance, but does not expect it to have a material impact on its financial statements.

Recent Accounting Pronouncements   In August 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (“ASU”) 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”). The guidance in ASU 2020-06 simplifies the accounting for convertible debt and convertible preferred stock by removing the requirements to separately present certain conversion features in equity. In addition, the amendments in the ASU 2020-06 also simplify the guidance in ASC Subtopic 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity, by removing certain criteria that must be satisfied in order to classify a contract as equity, which is expected to decrease the number of freestanding instruments and embedded derivatives accounted for as assets or liabilities. Finally, the amendments revise the guidance on calculating earnings per share, requiring use of the if-converted method for all convertible instruments and rescinding an entity’s ability to rebut the presumption of share settlement for instruments that may be settled in cash or other assets.   The amendments in ASU 2020-06 are effective for the Company for fiscal years beginning after December 15, 2021. Early adoption is permitted. The guidance must be adopted as of the beginning of the fiscal year of adoption. The Company is currently evaluating the impact of this new guidance, but does not expect it to have a material impact on its financial statements.

EX-101.SCH 6 when-20210331.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Related Parties link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Related Parties (Tables) link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - General (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Related Parties - Schedule of Related Party Transaction (Details) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 when-20210331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 when-20210331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 when-20210331_lab.xml XBRL LABEL FILE Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Merger Agreement [Member] Equity Components [Axis] Series B Convertible Preferred Stock [Member] Legal Entity [Axis] UCG, INC. [Member] Series B Preferred Stock [Member] Preferred Stock B [Member] Foreign Currency Translation Adjustments [Member] Income Statement Location [Axis] General and Administrative Expenses [Member] Research and Development Expenses [Member] Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement [Table] Statement [Line Items] Class of Stock [Axis] Assets Current Assets Cash and cash equivalents Accounts receivable, net Other current assets Total Current assets Right Of Use asset arising from operating lease Long term prepaid expenses Property and Equipment, Net Total assets Liabilities and Shareholders' Deficit Current Liabilities Accounts payable Right Of Use liabilities arising from operating lease Other accounts liabilities Total current liabilities Liability for employee rights upon retirement Long term loan from parent company Right Of Use liabilities arising from operating lease Total liabilities Stockholders' Deficit Preferred stock, value Common stock, par $0.0007, 110,000,000,000 shares authorized, 89,789,407,996 shares issued and outstanding at March 31, 2021 and December 31, 2020. Additional paid-in capital Foreign currency translation adjustments Accumulated deficit Total stockholders' deficit Total liabilities and stockholders' deficit Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Research and development expenses General and administrative expenses Operating loss Financing expenses, net Net loss Comprehensive loss Loss per share (basic and diluted) Balance Balance, shares Comprehensive loss for the period Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss for the period Adjustments required to reconcile net loss for the period to net cash used in operating activities: Depreciation and amortization Increase in liability for employee rights upon retirement Decrease in accounts receivable Decrease (increase) in other current assets Increase (decrease) in accounts payable Increase in other accounts liabilities Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Loans granted to related parties Proceeds from related parties Purchase of property and equipment Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Payments of lease liability Loan received from parent company Net cash provided by (used in) financing activities INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS AT END OF PERIOD Supplemental disclosure of cash flow information: Non cash transactions: Initial recognition of operating lease right-of-use assets Initial recognition of operating lease liability Organization, Consolidation and Presentation of Financial Statements [Abstract] General Accounting Policies [Abstract] Summary of Significant Accounting Policies and Basis of Presentation Related Party Transactions [Abstract] Related Parties Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Unaudited Interim Financial Statements Principles of Consolidation Use of Estimates Recent Accounting Pronouncements Schedule of Related Party Expenses Series [Axis] Number of shares issued Number of shares converted Aggregate amount of conversion shares Net loss Working capital Salaries and fees to officers Other accounts liabilities Long term loan from related party Liability for employee rights upon retirement Stock purchase agreement, description Computers and Software [Member] Foreign Currency Translation Adjustments [Member] Furniture and Office Equipment [Member] Gaya Rozensweig, Interim Chief Executive Officer [Member] George Baumoeh lAnd Gaya Rozensweig [Member] Giora Rozensweig, Interim Chief Executive Officer [Member] Irrevocable License and Royalty Agreement [Member] Lease Agreement [Member] Liability for employee rights upon retirement. Merger Agreement [Member] New Israeli Shekel [Member] Office Furniture and Equipment [Member] Other accounts liabilities, related parties. Preferred Stock B [Member] Research and Development Expenses [Member] Series B Convertible Preferred Stock [Member] Set-off Agreement [Member] UCG, INC. [Member] Working capital. Proceeds from related parties. Unaudited Interim Financial Statements [Policy Text Block] Initial recognition of operating lease right-of-use assets. Initial recognition of operating lease liability. Stock purchase agreement, description. Assets, Current Assets [Default Label] Liabilities, Current Operating Lease, Liability, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Research and Development Expense General and Administrative Expense Operating Income (Loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Other Current Assets Net Cash Provided by (Used in) Operating Activities Payments to Fund Long-term Loans to Related Parties Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Finance Lease, Principal Payments Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations OtherAccountsLiabilitiesRelatedParties LiabilityForEmployeeRightsUponRetirement EX-101.PRE 10 when-20210331_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2021	May 11, 2021
Cover [Abstract]
Entity Registrant Name	WORLD HEALTH ENERGY HOLDINGS, INC.
Entity Central Index Key	0000943535
Document Type	10-Q
Document Period End Date	Mar. 31, 2021
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		89,789,407,996
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2021

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current Assets
Cash and cash equivalents	$ 141,868	$ 359,949
Accounts receivable, net	13,360	5,086
Other current assets	47,205	42,178
Total Current assets	202,433	407,213
Right Of Use asset arising from operating lease	230,761
Long term prepaid expenses	23,995	24,883
Property and Equipment, Net	26,270	26,054
Total assets	483,459	458,150
Current Liabilities
Accounts payable	20,860	26,284
Right Of Use liabilities arising from operating lease	39,610
Other accounts liabilities	531,580	496,874
Total current liabilities	592,050	523,158
Liability for employee rights upon retirement	133,364	104,850
Long term loan from parent company	1,812,704	1,812,704
Right Of Use liabilities arising from operating lease	193,994
Total liabilities	2,732,112	2,440,712
Stockholders' Deficit
Preferred stock, value	3,500	3,500
Common stock, par $0.0007, 110,000,000,000 shares authorized, 89,789,407,996 shares issued and outstanding at March 31, 2021 and December 31, 2020.	62,852,585	62,852,585
Additional paid-in capital	(63,339,224)	(63,339,224)
Foreign currency translation adjustments	(5,495)	(5,495)
Accumulated deficit	(1,762,728)	(1,496,637)
Total stockholders' deficit	(2,248,653)	(1,982,562)
Total liabilities and stockholders' deficit	483,459	458,150
Series B Convertible Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, value	$ 2,709	$ 2,709

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Preferred stock, par value	$ 0.0007	$ 0.0007
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	5,000,000	5,000,000
Preferred stock, shares outstanding	5,000,000	5,000,000
Common stock, par value	$ 0.0007	$ 0.0007
Common stock, shares authorized	110,000,000,000	110,000,000,000
Common stock, shares issued	89,789,407,996	89,789,407,996
Common stock, shares outstanding	89,789,407,996	89,789,407,996
Series B Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.0007	$ 0.0007
Preferred stock, shares authorized	3,870,000	3,870,000
Preferred stock, shares issued	3,870,000	3,870,000
Preferred stock, shares outstanding	3,870,000	3,870,000

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Revenues	$ 32,649	$ 3,516
Research and development expenses	(172,771)	(99,948)
General and administrative expenses	(124,485)	(57,406)
Operating loss	(264,607)	(153,838)
Financing expenses, net	(1,484)	(9,208)
Net loss	(266,091)	(163,046)
Comprehensive loss	$ (266,091)	$ (163,046)
Loss per share (basic and diluted)	$ (0.00)	$ 0.00

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

+ Details

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited) - USD ($)	Preferred Stock [Member]	Preferred Stock B [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Foreign Currency Translation Adjustments [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2019		$ 2,709		$ (2,681)	$ (5,495)	$ (623,844)	$ (629,311)
Balance, shares at Dec. 31, 2019		3,870,000
Comprehensive loss for the period						(163,046)	(163,046)
Balance at Mar. 31, 2020		$ 2,709		(2,681)	(5,495)	(786,890)	(792,357)
Balance, shares at Mar. 31, 2020		3,870,000
Balance at Dec. 31, 2020	$ 3,500	$ 2,709	$ 62,852,585	(63,339,224)	(5,495)	(1,496,637)	(1,982,562)
Balance, shares at Dec. 31, 2020	5,000,000	3,870,000	89,789,407,996
Comprehensive loss for the period						(266,091)	(266,091)
Balance at Mar. 31, 2021	$ 3,500	$ 2,709	$ 62,852,585	$ (63,339,224)	$ (5,495)	$ (1,762,728)	$ (2,248,653)
Balance, shares at Mar. 31, 2021	5,000,000	3,870,000	89,789,407,996

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 16 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss for the period	$ (266,091)	$ (163,046)
Adjustments required to reconcile net loss for the period to net cash used in operating activities:
Depreciation and amortization	13,597	10,362
Increase in liability for employee rights upon retirement	28,514	2,777
Decrease in accounts receivable	(8,274)	(1,738)
Decrease (increase) in other current assets	(4,139)	(12,719)
Increase (decrease) in accounts payable	(5,422)	7,983
Increase in other accounts liabilities	37,178	31,606
Net cash used in operating activities	(204,637)	(124,775)
CASH FLOWS FROM INVESTING ACTIVITIES:
Loans granted to related parties		(228,898)
Proceeds from related parties	3,521
Purchase of property and equipment	(1,668)	(7,675)
Net cash used in investing activities	1,853	(236,573)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of lease liability	(15,297)	(6,942)
Loan received from parent company		91,785
Net cash provided by (used in) financing activities	(15,297)	84,843
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(218,081)	(276,505)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	359,949	359,461
CASH AND CASH EQUIVALENTS AT END OF PERIOD	141,868	82,956
Non cash transactions:
Initial recognition of operating lease right-of-use assets	242,906
Initial recognition of operating lease liability	$ (242,906)

XML 17 R7.htm IDEA: XBRL DOCUMENT

General

3 Months Ended

Mar. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

General

NOTE 1 – GENERAL

Operations

Merger Transaction

The Company, collectively with SG, Sub and RNA are hereunder referred to as the “Group”.

Going concern uncertainty

The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Risk factors

XML 18 R8.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and Basis of Presentation

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Summary of Significant Accounting Policies and Basis of Presentation

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

Unaudited Interim Financial Statements

Principles of Consolidation

Use of Estimates

Recent Accounting Pronouncements

XML 19 R9.htm IDEA: XBRL DOCUMENT

Related Parties

3 Months Ended

Mar. 31, 2021

Related Parties

NOTE 3 – RELATED PARTIES

Transactions and balances with related parties

	Three months ended March 31
	2021		2020
General and administrative expenses:
Salaries and fees to officers		39,413		15,107

Research and development expenses:
Salaries and fees to officers		22,653		8,536

Balances with related parties and officers:

	As of March 31,		As of December 31,
	2021		2020

Other accounts liabilities		183,135		191,994
Long term loan from related party		1,812,704		1,812,704
Liability for employee rights upon retirement		102,516		95,451

XML 20 R10.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Mar. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

NOTE 4 – COMMITMENTS AND CONTINGENCIES

A hearing was set for January 6, 2021 whereupon mediation was ordered. The Company has been in discussions with EL to resolve this issue.

XML 21 R11.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Unaudited Interim Financial Statements	Unaudited Interim Financial Statements The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiary, prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and with the instructions to Form 10-Q. In the opinion of management, the financial statements presented herein have not been audited by an independent registered public accounting firm but include all material adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the financial condition, results of operations and cash flows for the three-months ended March 31, 2021. However, these results are not necessarily indicative of results for any other interim period or for the year ended December 31, 2021. The preparation of financial statements in conformity with GAAP requires the Company to make certain estimates and assumptions for the reporting periods covered by the financial statements. These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts could differ from these estimates. Certain information and footnote disclosures normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission (“SEC”). These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company’s Annual Report on published on the OTCIQ Alternative Reporting System, for the year ended December 31, 2021.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements are prepared in accordance with US GAAP. The consolidated financial statements of the Company include the Company and its wholly-owned and majority-owned subsidiaries. All inter-company balances and transactions have been eliminated.
Use of Estimates	Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to the going concern assumptions.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (“ASU”) 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”). The guidance in ASU 2020-06 simplifies the accounting for convertible debt and convertible preferred stock by removing the requirements to separately present certain conversion features in equity. In addition, the amendments in the ASU 2020-06 also simplify the guidance in ASC Subtopic 815-40, Derivatives and Hedging: Contracts in Entity’s Own Equity, by removing certain criteria that must be satisfied in order to classify a contract as equity, which is expected to decrease the number of freestanding instruments and embedded derivatives accounted for as assets or liabilities. Finally, the amendments revise the guidance on calculating earnings per share, requiring use of the if-converted method for all convertible instruments and rescinding an entity’s ability to rebut the presumption of share settlement for instruments that may be settled in cash or other assets. The amendments in ASU 2020-06 are effective for the Company for fiscal years beginning after December 15, 2021. Early adoption is permitted. The guidance must be adopted as of the beginning of the fiscal year of adoption. The Company is currently evaluating the impact of this new guidance, but does not expect it to have a material impact on its financial statements.

XML 22 R12.htm IDEA: XBRL DOCUMENT

Related Parties (Tables)

3 Months Ended

Mar. 31, 2021

Schedule of Related Party Expenses

Transactions and balances with related parties

	Three months ended March 31
	2021		2020
General and administrative expenses:
Salaries and fees to officers		39,413		15,107

Research and development expenses:
Salaries and fees to officers		22,653		8,536

Balances with related parties and officers:

	As of March 31,		As of December 31,
	2021		2020

Other accounts liabilities		183,135		191,994
Long term loan from related party		1,812,704		1,812,704
Liability for employee rights upon retirement		102,516		95,451

XML 23 R13.htm IDEA: XBRL DOCUMENT

General (Details Narrative) - USD ($)		3 Months Ended
General (Details Narrative) - USD ($)	Apr. 27, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Preferred stock, par value		$ 0.0007		$ 0.0007
Cash and cash equivalents		$ 141,868		$ 359,949
Net loss		(266,091)	$ (163,046)
Accumulated deficit		(1,762,728)		$ (1,496,637)
Working capital		$ (389,617)
Series B Convertible Preferred Stock [Member]
Preferred stock, par value		$ 0.0007		$ 0.0007
Merger Agreement [Member] \| Series B Convertible Preferred Stock [Member] \| UCG, INC. [Member]
Number of shares issued	3,870,000
Preferred stock, par value	$ 0.0007
Merger Agreement [Member] \| Series B Preferred Stock [Member]
Number of shares converted	100,000
Aggregate amount of conversion shares	387,000,000,000

XML 24 R14.htm IDEA: XBRL DOCUMENT

Related Parties - Schedule of Related Party Transaction (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Other accounts liabilities	$ 183,134	$ 191,994
Long term loan from related party	1,812,704	1,812,704
Liability for employee rights upon retirement	102,516	95,451
General and Administrative Expenses [Member]
Salaries and fees to officers	39,413	15,107
Research and Development Expenses [Member]
Salaries and fees to officers	$ 22,653	$ 8,536

- Definition

Carrying amount as of the balance sheet date of obligations due all related parties.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(C))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.17)
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(3),(4))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

+ Details

XML 25 R15.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Narrative)

Oct. 27, 2020

Commitments and Contingencies Disclosure [Abstract]

Stock purchase agreement, description

EXCEL 26 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 27 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 28 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 29 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 53 175 1 false 12 0 false 3 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://worldhealthenergy.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://worldhealthenergy.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://worldhealthenergy.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://worldhealthenergy.com/role/StatementsOfComprehensiveLoss Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited) Sheet http://worldhealthenergy.com/role/StatementsOfChangesInShareholdersDeficit Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://worldhealthenergy.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - General Sheet http://worldhealthenergy.com/role/General General Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation Sheet http://worldhealthenergy.com/role/SummaryOfSignificantAccountingPoliciesAndBasisOfPresentation Summary of Significant Accounting Policies and Basis of Presentation Notes 8 false false R9.htm 00000009 - Disclosure - Related Parties Sheet http://worldhealthenergy.com/role/RelatedParties Related Parties Notes 9 false false R10.htm 00000010 - Disclosure - Commitments and Contingencies Sheet http://worldhealthenergy.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 10 false false R11.htm 00000011 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation (Policies) Sheet http://worldhealthenergy.com/role/SummaryOfSignificantAccountingPoliciesAndBasisOfPresentationPolicies Summary of Significant Accounting Policies and Basis of Presentation (Policies) Policies http://worldhealthenergy.com/role/SummaryOfSignificantAccountingPoliciesAndBasisOfPresentation 11 false false R12.htm 00000012 - Disclosure - Related Parties (Tables) Sheet http://worldhealthenergy.com/role/RelatedPartiesTables Related Parties (Tables) Tables http://worldhealthenergy.com/role/RelatedParties 12 false false R13.htm 00000013 - Disclosure - General (Details Narrative) Sheet http://worldhealthenergy.com/role/GeneralDetailsNarrative General (Details Narrative) Details http://worldhealthenergy.com/role/General 13 false false R14.htm 00000014 - Disclosure - Related Parties - Schedule of Related Party Transaction (Details) Sheet http://worldhealthenergy.com/role/RelatedParties-ScheduleOfRelatedPartyTransactionDetails Related Parties - Schedule of Related Party Transaction (Details) Details 14 false false R15.htm 00000015 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://worldhealthenergy.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://worldhealthenergy.com/role/CommitmentsAndContingencies 15 false false All Reports Book All Reports when-20210331.xml when-20210331.xsd when-20210331_cal.xml when-20210331_def.xml when-20210331_lab.xml when-20210331_pre.xml http://xbrl.sec.gov/dei/2021 http://fasb.org/us-gaap/2021-01-31 true true ZIP 31 0001493152-21-011863-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-21-011863-xbrl.zip M4$L#!!0 ( %B"L5)924.'#"L #3, 0 1 =VAE;BTR,#(Q,#,S,2YX M;6SM?6MSXSBNZ/=;=?\#3W;/UDR5DUA^.STSI]QY].2>GB23I'?NWB];BD0[ MVI$E'SWRV%]_ 9"2*%NV)5M^=30]G78LB@!! 1 OSIO][&-GOAGF^YSL]' MVDG]B'''<$W+&?U\].WA>/!P?GU]Q/[KE__]OQC\]]-_'!^S*XO;YAF[<(WC M:V?H?F(W^IB?L2_N-XG]G?=#O$;]\JRNL46]H]6938UK]=_:[QBZN;D[>AC"8"SV =O@8FM7;\$/K/C;J M9UKC3.O]OYQ ST(_1AH_:TN_Q.O__3VY-G6&?YD,"&.?_;F6S\?*0-];9ZX MWNBT4:]KI__WMZ\/QC,?Z\>6XP>Z8_"CZ"W;D_K]_NG]#1J.M,2@4
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
#"&P?VZU$27S#'2F'NXVK16VVF2JD'(\K*D:77-V3Z0!?%Y^ ME92,Z3JXZ#1,R'UVUTFCEFWR\N5(:0V=VR-E2\0\&4Y[GY+M)[2"W9M.IZUJ.N89B]ZG1*0/@\ZI??4++G?D@;2W]_[PX[I M-\#IB07 UVA=>*K UM#;"SA=.CXL@=O[8R\&E8&=9O[[-P&8 M>=)!R($K[SO/4QI=,#I-,)]?,$1%^40E2S5DYG)*8W4 MOKB^M0+2>IOS@/+;F]NQA\8+1>X%K 3AZ'4QM,/-I3?G9&?F8H_<2YT/YB$ M=#(?K,T+:CS]AZ_L/!\$8.;)@)+5%.OW7:\YD95>J&#ZK*\T\]L@!J6R-^?B M#KPP&T5?S$AAF $M1_BN;BI1*P6U@MYF\XR;TY!#LC MV1ZYO1_RE;[J?S7WO48'A937.N!RVTF:7W5X]ACJ MFS)N9&LYFTQPW73AN>L!-=K>_)8MIAINN/K'-O$U0",B%DR@^%?.TH6^$D>$ MC,J%0(JCW$?,:$V/^KRU $>*O13S;LG3"SE]\X]GXA:''?I\[MUK(W]I9V/2 MQ2+6<*-X!?>83AB?(^#CD] ,H(;5_[DTN&%9HN/+6H714%;VR:E&H_5L6Q\? M CB:X%E >>WOH)LE2:RMIMV0;-@_&E.Y!D*Q"KV84GW[PM5DO4VN_20W9#I+ MV"05V!BIIG)JDQ&4P]Y\A/8LL-TT=LSE*M2EZE0I3*5"#E#V^G,+]LO>%E@^ M79697W:^KMK& <0?@T&@IA$Q$RG'\I=5:I?W7/,IHGG<_],QR.Q,P'4!H<)C MQT\'))M'CHZR=WH3^"XJ/-']19K49UG/[SV!55F2X[.-G1I7^6KRGFCQJ3>Y M3>=SQ)=7DULB.\,)"=4F>A8<*WO#:ZERJ#RN-%*7"(NK25'OZB[HIW(7E!>A MCCH7"@F>2@E6Q02(1H$N2"7>*,KEF<-M.)I/#M;(.%U]U;$,Z#^@\HY[A6;* MRNLN*UQ\:L"&,*>-)OFAW"1SH6 EY?22KJ=M.'VWF"1)N3V:VUBSI-O+QZIK M9S5<6V7BN,U!B=RZJ,P:)Y^:G[ICDF3'&.0@.=3NNRFFH:DM'A^5VV(A!SW^ M;>;A^,)0@VI/"C0W4\ML7%^1VEA50+.US<=QRVU%=,5=J_;0^=22=YD)K[ZM M;O+'?K-$ZO"O)BAR.M=WYUAS M4JVH)RQ"0IQ1^6-8;.[@EF2?D_-[<&R9; N63W.<36>!?G3%,&3CY?J.[@-9SA*8]ESF.JIP8?XZZQSVD\O0EO$?&J<^5;=2-W<'HM+ MQ+-'C*O;YSO#1E_P)IOJD.!(WOF]DFY$?%-:: M8_GF5%L5GV9=73K(?I,3$,Q/IQSK@FL?.3*D=>XD:6=U1>=7+0J>K-37_<,P M1D+DC\P"'P#=%O&CP=@-0-M:%'P]3EV/A8HUO?I9E=8S,DP&5O8U5FC23R=U MBSG!XK.<7-YCGA!I*L#'/)4T5-AU-V8VHF)/90>%+UU75FF[%UAKA5R[#IO) M@FC1 TD"AV^G[/XPPB3C1_Z@:=&$R%^^7> IBL]HHEXEKQX]9*JM1)YU497C M156]"X;P'.!F11O' )ED,X5C6*L0V\)TL\;]]/!?A[^.+X>U_?AF$F>]]18@ M%5NI%JWB$# MX^$)B9N#R37B5UPK'/V.XA1+#73US21"Y5W/B, LV@'B"8O9%$YHQZBN=V9T M^U00M-HJYWR<'<@6'PA+;:'J.H3&&*?HM#F;3^HIY=\W4](^ZFRP4# MZ(DUY ?]2\?[3Y,AXGPI==,=4$U#AHF[?B<&WIAMX/"$PEZ?B7/_/F>WS\ E MLG'Z\ A<^6WSTS!,YZG>]A_A"0E);>!'LZSK%U7 ],*!Z.G<^1^,?Y<%#]&" M)$]'DDMKMW(BUP^/-,-;56LCCIX$)(?FN*]!L&J !6)7OQV M&10*6<>?O :&];D-M)>Q(FUCNU[#0+S9A;OP+PPDF^ \U5 5I1"LW1RM%=HC M8FKU\"0PQ%#'IKW2!C$_2 (8'XRQCCSL'5&6!Y.J1UNC.:%$]<\JE/3L<:&> MLV_:O0.*NW8Q@@RS1)\5,CW-NF\D3#)3M=@>X7L<,_W<15X# MVI1^2'3U*F3A74#0RTI08=<='FSE:P=%:V_2/>9WS M_TBC%Y7>_5D_*ZHC" M,/O%W!K!&>S-QHPE)#TURO4]?.>,KU\,5SY<\>T(U1[=PV(*X=0[\ZFK4X JMO \Y]^HO^YDOO*3_P=02P$"% ,4 " !8@K%264E# MAPPK TS $ $0 @ $ =VAE;BTR,#(Q,#,S,2YX;6Q0 M2P$"% ,4 " !8@K%2"#*<2R8( #*.0 $0 @ $[*P M=VAE;BTR,#(Q,#,S,2YXZ@) #X: M%0 @ &0,P =VAE;BTR,#(Q,#,S,5]C86PN>&UL4$L! A0# M% @ 6(*Q4H76#EU=#0 Y[D !4 ( !:ST '=H96XM M,C R,3 S,S%?9&5F+GAM;%!+ 0(4 Q0 ( %B"L5)>BC#AUA\ %6K 0 5 M " ?M* !W:&5N+3(P,C$P,S,Q7VQA8BYX;6Q02P$"% ,4 M " !8@K%2+65SJML4 =+@$ %0 @ $$:P =VAE;BTR E,#(Q,#,S,5]P&UL4$L%!@ & 8 B@$ !* $! end